Kura Oncology
(KURA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,124 | 7 | 5 | 4 | N/A |
| Receivables | 30 | N/A | N/A | N/A | N/A |
| TOTAL | $1,196 | $9 | $8 | $7 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 27 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 155 | 0 | 0 | 0 | 0 |
| TOTAL | $182 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,378 | $9 | $8 | $7 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 980 | 0 | 2 | 3 | 0 |
| Accrued Expenses | N/A | 23 | 17 | 12 | N/A |
| TOTAL | $3,016 | $133 | $104 | $75 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,795 | 0 | 0 | 0 | 0 |
| TOTAL | $1,795 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,811 | $133 | $104 | $75 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | 1 | 1 | 1 | N/A |
| Retained earnings | -3,671 | -174 | -145 | -118 | N/A |
| TOTAL | $-3,433 | $-124 | $-95 | $-68 | $N/A |
| Total Liabilities And Equity | $1,378 | $9 | $8 | $7 | $0 |